Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)

Print Options
PrintThe Whole
Directive
PrintThis
Annex
only
Changes over time for: ANNEX IV


Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Status:
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
ANNEX IVU.K.STORAGE, TRANSPORT AND DISTRIBUTION CONDITIONS FOR BLOOD AND BLOOD COMPONENTS (as referred to in Article 5)
1.STORAGEU.K.
1.1.Liquid storageU.K.
Component | Temperature of storage | Maximum storage time |
---|
Red cell preparations and whole blood (if used for transfusion as whole blood) | + 2 to + 6 °C | 28 to 49 days according to the processes used for collection, processing and storage |
Platelet preparations | + 20 to + 24 °C | 5 days; may be stored for 7 days in conjunction with detection or reduction of bacterial contamination |
Granulocytes | + 20 to + 24 °C | 24 hours |
1.2.CryopreservationU.K.
Component | Storage conditions and duration |
---|
Red blood cells | Up to 30 years according to processes used for collection, processing and storage |
Platelets | Up to 24 months according to processes used for collection, processing and storage |
Plasma and cryoprecipitate | Up to 36 months according to processes used for collection, processing and storage |
Cryopreserved red blood cells and platelets must be formulated in a suitable medium after thawing. The allowable storage period after thawing to depend on the method used. |
2.TRANSPORT AND DISTRIBUTIONU.K.
Transport and distribution of blood and blood components at all stages of the transfusion chain must be under conditions that maintain the integrity of the product.
3.ADDITIONAL REQUIREMENTS FOR AUTOLOGOUS DONATIONSU.K.
3.1.Autologous blood and blood components must be clearly identified as such and stored, transported and distributed separately from allogeneic blood and blood components.U.K.
3.2.Autologous blood and blood components must be labelled as required by Directive 2002/98/EC and in addition the label must include the identification of the donor and the warning ‘FOR AUTOLOGOUS TRANSFUSION ONLY’.U.K.
Back to top